ARN22089 is an oral active CDC42 GTPase interaction inhibitor that blocks tumour growth in BRAF mutant mouse melanoma models and patient-derived xenografts (PDXs) in vivo.
Molecular Weight:
373.49
Purity:
98.37%
CAS Number:
[2248691-29-2]
Formula:
C23H27N5
Target:
Ras|||CDK
T85727
T85727
* VAT and and shipping costs not included. Errors and price changes excepted